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ABSTRACT  
 
Background. The importance of vasopressin and/or urine concentration in various 
kidney, cardiovascular and metabolic diseases has been emphasized recently. Due 
to technical constraints, urine osmolality (Uosm), a direct reflect of urinary 
concentrating activity, is rarely measured in epidemiologic studies.  
Methods. We analyzed two possible surrogates of Uosm in 4 large population-based 
cohorts (total n=4,247) and in patients with chronic kidney disease (CKD, n=146). An 
estimated Uosm (eUosm) based on the concentrations of sodium, potassium and urea, 
and a urine concentrating index (UCI) based on the ratio of creatinine concentrations 
in urine and plasma were compared to the measured Uosm (mUosm). 
Results. eUosm is an excellent surrogate of mUosm, with a highly significant linear 
relationship and values within 5% of mUosm (r=0.99 or 0.98 in each population 
cohort). Bland-Altman plots show a good agreement between eUosm and mUosm with 
mean differences between the two variables within ±24 mmol/L. This was verified in 
men and women, in day and night samples, and in CKD patients. The relationship of 
UCI with mUosm is also significant but is not linear and exhibits more dispersed 
values. Moreover, the latter index is no longer representative of mUosm in patients 
with CKD as it declines much more quickly with declining GFR than mUosm.   
Conclusion. The eUosm is a valid marker of urine concentration in population-based 
and CKD cohorts. The UCI can provide an estimate of urine concentration when no 
other measurement is available, but should be used only in subjects with normal 
renal function.   
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INTRODUCTION 
 The interest in the influence of the antidiuretic hormone vasopressin (ADH or 
AVP) as a significant player in various kidney, cardiovascular and metabolic diseases 
has been revived recently [1-4]. The availability of non-peptide, orally active selective 
vasopressin receptor antagonists (vaptans) [5, 6] and of a reliable ELISA for the 
measurement of copeptin, a validated surrogate of vasopressin [7, 8], has opened 
the door for a number of studies addressing the vasopressin/thirst pathway and 
osmoregulation in general (see review in [9]). 
 
 Independent of the well-known contribution of ADH to various forms of water 
disorders, recent epidemiological studies have shown significant associations 
between indices of the vasopressin/hydration system and the incidence or 
progression of diseases including chronic kidney disease (CKD), autosomal 
dominant polycystic kidney disease (ADPKD), diabetic nephropathy, obesity, 
metabolic syndrome, and insulin resistance [10-14, 4, 15-21]. A number of 
experimental studies have demonstrated the adverse effects of vasopressin or a low 
level of hydration in animal models of these disorders [22, 10, 23-26]. A recent 
double-blind, placebo-controlled clinical trial, using a selective vasopressin V2 
receptor antagonist, tolvaptan, proved to bring significant benefit over a 3 year period 
in patients with ADPKD and well preserved renal function [27]. 
 
 Because AVP is difficult to measure due to its small mass, very low circulating 
concentrations, poor stability in vitro, and time-consuming assay, most of the recent 
studies dealing with this hormone rely on the measurement of copeptin (a peptide 
that is part of the pre-pro-hormone containing vasopressin) in plasma or, more 
indirectly, on fluid intake or daily urine volume [28, 29]. Urine osmolarity (Uosm), the 
most direct parameter reflecting the action of AVP on distal tubular segments of the 
kidney, is rarely measured due to technical constraints, and is thus usually not 
available in epidemiologic studies.  
 
Various surrogates of Uosm have been used in clinical studies. They include 
the specific urine density or the refraction index that give only an approximate value 
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of the solute content in the urine and are subjected to several biases including 
distorsion in the case of proteinuria and poor precision of readings. Two other 
surrogates are the Urine Concentrating Index (UCI) based on the handling of 
creatinine by the kidney [30, 31], and the estimated urine osmolarity (eUosm) based 
on the concentration of the three main osmoles present in the urine: sodium, 
potassium and urea [31, 32]. To our knowledge, the validity of these two surrogates 
has not been evaluated in large, population-based cohorts with normal or altered 
renal function. The aim of the present study was to assess the value of eUosm and 
UCI compared to measured Uosm (mUosm) in large population-based and CKD 
cohorts, and to test the influence of sample type, gender and age on these markers.  
 
 
SUBJECTS and METHODS 
 
Cohorts 
 The general characteristics of the subjects belonging to the different cohorts 
are presented in Table 1.  
 
1. Generation Scotland: SFHS (GS:SFHS) and CROATIA-Korcula  
 Aberdeen and Glasgow subjects were selected from the Generation Scotland 
study, a family-based genetic epidemiology study that included 24,000 volunteers 
from across Scotland, as previously described [33]. Biological samples including 
morning spot urine were collected during participation from 2006-2011 [34]. We also 
studied subjects from the CROATIA-Korcula cohort, a family-based, cross-sectional 
study from the island of Korcula (Croatia) that initially included 965 subjects, as 
previously described [35]. Studies of these three cohorts included clinical information, 
biochemical measurements, and lifestyle and health questionnaires. For the present 
study, subjects from these three cohorts were randomly selected for measurement of 
Uosm (n=554 from GS:SFHS Aberdeen, 2305 from GS:SFHS Glasgow and 463 from 
CROATIA-Korcula). All participants provided written informed consent. For  
GS:SFHS national ethical approval has been obtained from the National Health 
Service Tayside Research Ethics committee. The CROATIA-Korcula study was 
approved by the Ethical Committee of the Medical School, University of Zagreb.  
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2. SKIPOGH 
 SKIPOGH (Swiss Kidney Project on Genes in Hypertension) is a family- and 
population-based cross-sectional multi-center study that examines the genetic 
determinants of blood pressure. Participants were recruited in 2009-2013 in the 
cantons of Bern and Geneva, and the city of Lausanne. Detailed methods have been 
previously described [36, 37]. The study visit was performed in the morning after an 
overnight fast. Participants were asked to bring urine of the previous 24 h collected 
separately during day and night periods defined according to each participant’s self-
reported bedtime and wake-up time. The SKIPOGH study was approved by the 
Human Research Ethics Committee of Lausanne University Hospital and University 
of Lausanne (Lausanne, Switzerland), by the Ethics Committee for the Research on 
Human Beings of Geneva University Hospitals (Geneva, Switzerland), and by the 
Ethics Committee of the Canton of Bern, (Bern, Switzerland).  
 
3. CKD patients  
 This study includes 146 out-patients with CKD of diverse etiologies and 
various levels of renal dysfunction, attending the Nephrology Department of Necker 
Hospital (Paris, France) in 1993 for a bi-annual checkup [38, 19]. All patients 
provided 24-h urine. Informed consent was obtained for storage of the samples and 
additional future measurements to enable a more complete understanding of the 
pathophysiological characteristics related to CKD. On the freshly collected plasma 
and urine samples, osmolality was measured with a freezing point osmometer 
(Roebling, Berlin, Germany). Creatinine concentration was measured by the Jaffe 
colorimetric method and creatinine clearance in ml per 1.73 m2 was used as an 
estimate of GFR. Concentration of urinary solutes was measured with a classical 
automatic multianalyzer.  
 
Measurements in Plasma and Urine Samples 
 In the 4 population-based cohorts, urine samples were kept frozen at -80°C 
until measurements of Uosm and urinary solute concentrations. Sodium, potassium, 
glucose, creatinine, and urea were measured with a Beckman Coulter Synchron 
System Assays (Unicell DxC Synchron Clinical System). The CKD-EPI formula was 
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used to calculate eGFR [39]. Uosm was measured on 20 µl samples by the freezing-
point depression technique using an Advanced Osmometer (Massachusetts 02062, 
USA). A control (Clinitrol 290) and a set of calibration standards (50, 850 and 2000 
mosm/kg H2O) were used before running each batch. The intra-assay coefficient of 
variability was 0.19 % and the inter-assay coefficient of variability was 1.32 %.  
 
Calculations and Statistical Analyses 
 Most modern osmometers measure the osmolality of the fluids in 
milliosmoles per kg water (mosm/kg H2O) (see footnote 1). Osmolarity expresses 
the concentration of osmotically active molecules in milliosmoles per liter of water 
(mosm/L). Sweeny and Beuchat described the technical aspects and limitations of 
osmometry methods and provided detailed considerations about the concepts of 
osmotic pressure, osmolarity, osmolality, and solute concentrations [40].  
 
Footnote 1. The terms osmolarity or osmolality should be prefered to "osmotic 
pressure" because this physical osmotic force is not a pressure. It was named in this 
way in the past, when osmolarity was evaluated indirectly as a hydrostatic pressure 
generated by an unknown fluid opposed to a reference fluid, separated by a semi-
permeable membrane. The measurements were expressed in mm height between 
the levels of the two fluids in the two compartments. 
 
Estimated urine osmolarity (eUosm) 
 The major urinary solutes, accounting for more than 90% of all urinary 
osmoles, are urea and the two cations sodium and potassium along with their 
accompanying anions. Thus, their cumulated concentrations (in mmol/L) should be 
close to the actual Uosm (in mosm/L). An "estimated" Uosm can be calculated 
according to the following formula: 
  eUosm = (UNa + UK )*2 + Uurea 
where UNa, UK and Uurea are the urinary concentrations of sodium, potassium and 
urea, respectively, in mmol/L. (UNa + UK) is multiplied by 2 to account for the 
accompanying anions. If urea was measured as urea nitrogen, it should be 
remembered that there are two atoms of nitrogen (MW = 14) per molecule of urea. 
Urea in mmol/L = urea nitrogen in mg/dL x 0.357 (explanation: urea nitrogen in 
mg/dL multiplied by 10 [conversion of dL to L] and divided by 14x2 [mg N per mmol 
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urea]. In case of significant glycosuria, glucose concentration can be added to the 
formula. 
 
 
Urine Concentrating Index (UCI) 
 Creatinine is freely filtered and is assumed to undergo negligible secretion or 
reabsorption along the nephron when kidney function is normal. Thus, the 
concentration of creatinine in urine relative to that in plasma (Ucreat and Pcreat, 
respectively), i.e., the ratio of urine-to-plasma creatinine concentrations, is 
proportional to the fraction of filtered water that has been reabsorbed to concentrate 
the solutes in the urine. This ratio provides an Index of Urine Concentration (UCI), a 
ratio that has no unit:  
  UCI = Ucreat / Pcreat 
 
Statistical analyses 
 The Statistical Package for Social Sciences (SPSS) version 19 (IBM 
Corporation, New York) and GraphPad Prism 5 were used to carry out the statistical 
analyses and generate the figures. Results are shown as means ± SEM for normally 
distributed variables, or as medians and 25%-75% interquartile range (IQR) for other 
variables. The agreement between mUosm and eUosm was assessed by Bland-Altman 
plots. The Shapiro-Wilk  test was used to assess the distribution of mUosm in the 
SKIPOGH study. Correlations were studied using Pearson's correlation analysis (in 
case of normality) or Spearman’s rho test (for other variables). Wilcoxon signed-rank 
test was used to compare repeated measures for day and night urine samples of the 
SKIPOGH subjects. The significance level was set at 5 %. 
 
 
RESULTS 
 
1. Uosm surrogates in population-based cohorts 
 
Large variations in urine concentration are observed among individuals. The 
mUosm in different subjects varies from ≈ 150 to 1,200 mosm/kg H2O in spot urine of 
the three population-based cohorts as well as in day and night urine of the SKIPOGH 
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cohort (Figures 1A and 2B). A substantial number of subjects (21 %) dilute their 
urine below plasma osmolality whereas others (9 %) concentrate their urine up to 
three times more than the level of plasma osmolality (Figure 2A). These extreme 
mUosm are not associated with differences in eGFR. 
 Highly significant linear correlations are observed between mUosm and eUosm in 
all populations (CROATIA-Korcula r=0.98,GS:SFHS  Aberdeen r=0.98, GS:SFHS 
Glasgow r=0.99) (Figures 1A and 2B). The best fit linear regression lines are almost 
superimposed with the medians. Bland-Altman plots show a good agreement 
between eUosm and mUosm in the three population based cohorts(Supplementary 
Table 1). This is reflected in the small bias values (CROATIA-Korcula bias=24, 
GS:SFHS Aberdeen bias= -6, GS:SFHS Glasgow bias= -23), and relatively narrow 
precision range (CROATIA-Korcula -44 to 90, GS:SFHS Aberdeen -54 to 43, 
GS:SFHS Glasgow -80 to 34). Plot for the GS:SFHS Aberdeen population is given as 
an example in Figure 3.  
 
 Although the relations between UCI and mUosm are significant, they exhibit a 
relatively large dispersion of individual values, increasing with increasing osmolality 
(Figures 1B and 2C). Nonetheless, as an average, the ratio of UCI to mUosm is fairly 
constant (0.20, 0.21 and 0.22 for mUosm = 300, 600 and 900 mosm/kg H2O, 
respectively). UCI can be approximately converted to osmolality by the following 
quadratic formula : mUosm = 5 UCI – 0.007 UCI
2 + 83.   
 
 The possible influence of glycosuria that occured in some subjects on eUosm 
was evaluated. Among 3322 subjects of the three cohorts in which urinary glucose 
was available, 58 exhibited glucosuria > 1.66 mmol/L [41] (mean ± SEM 11.58 ± 2.28 
mmol/L; range 1.7 to 86.8). Their age and eGFR were 57.0 ± 1.8 y and 86.8 ± 2.4 
ml/min.1.73 m2, respectively. Measured Uosm in these subjects was 642 ± 32 
mosm/kg H2O. Estimated Uosm, calculated without or with the addition of urinary 
glucose was 624 ± 31 and  635 ± 32 mosm/L respectively, both within 3% of mUosm. 
 
 Urine osmolality is known to be higher in men than in women. This was 
verified in the cohorts of the present study (Supplementary Table 2): men exhibited 
higher mUosm and eUosm than women although the magnitude of this gender 
difference differed among the three populations. eUosm was very close to mUosm in 
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both genders and the men/women ratio of eUosm was very similar to that for mUosm. 
For UCI, there was a tendency for more inter-individual variation in women than in 
men as well as lower men/women ratios which tended to underestimate the gender 
difference (Supplementary Table 2).  
 
2. Uosm surrogates in day and night urine 
 
 In healthy subjects, urine is usually more concentrated during the night than 
during the day. We investigated if the relationships between mUosm, eUosm and UCI 
are comparable in day and night urine of the 925 subjects of the SKIPOGH study 
(Figure 2A). The Shapiro-Wilk  test indicates that these variables diverge from a 
normal distribution (shown by a thin curve). Mean mUosm ± SEM during day and night 
was respectively 520 ± 4 and 572 ± 7 mosm/kg H2O. Median [IQR] values were 457 
[334-676] and 541 [356-777] mosm/kg H2O, respectively (p <0.001, Wilcoxon signed-
rank test). The histograms of mUosm during day and night do not follow a normal 
distribution and there is a tendency for a bimodal distribution during the night.  
 
 Measured and estimated Uosm values exhibit highly significant linear 
correlations in both day and night urine (Figure 2B), as also observed in the spot 
urine of the other cohorts. Bland-Altman plots show a good agreement between 
eUosm and mUosm in day and night urine, as reflected by the small bias values (day  
bias=9, night  bias= 24), and the precision range (day  -71 to 89, night  -66 to 114) 
(Figure 3 and Supplementary Table 1). The relations between UCI and mUosm are 
best described by quadratic correlations. Thin red lines show the 95% confidence 
intervals. As in the three cohorts shown in Figure 1, UCI vs mUosm values were more 
widely dispersed than eUosm vs mUosm values. 
 
3. Uosm surrogates in CKD patients 
 
 Table 2 compares the values of eUosm and UCI to those of mUosm in CKD 
patients, according to their level of renal function. In all CKD classes, eUosm is very 
close to mUosm. Both variables decline in parallel with declining eGFR. Bland-Altman 
plot show a relatively good agreement between the two methods, as reflected by the 
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small bias value (15) and the precision range (-37 to 67) (Figure 3 and 
Supplementary Table 1). In contrast, UCI declines much more dramatically than 
mUosm. These differences are due mostly to the progressive rise in plasma creatinine 
concentration (from 91 ± 5 to 514 ± 34 µmol/L in the two extreme classes, a 5.6 fold 
increase) while urine creatinine concentration declines only two-fold as a result of a 
lower total creatinine excretion and a moderately higher 24-h urine volume. In these 
patients, a spot urine sample was collected in the morning following the 24-h urine 
collection. (Table 2). mUosm in morning urine is 10-20 % higher than mUosm in 24-h 
urine, a difference that seems independent of the level of renal function. 
 
 
DISCUSSION 
 
 The urine concentrating activity of the human kidney was rarely investigated, 
except in a few conditions such as urolithiasis and diabetes insipidus. Recent 
experimental and epidemiological findings have renewed the interest in the 
components of the water balance and in the parameters reflecting this integrative 
function [22, 24, 1, 28, 29, 9, 4, 42, 32, 43, 18]. It is indeed quite different for the 
kidney to excrete a daily osmolar load of 900 mosm in 1 liter of urine at 900 mosm/L 
or in 3 liters of urine at 300 mosm/L. Increased urine concentration (associated with 
increased solute-free water reabsorption) results in a lower fractional excretion of 
several solutes and in a significant hyperfiltration that is, at least in part, mediated by 
vasopressin acting on renal V2 receptors. It has been proposed that this 
hyperfiltration is mediated by changes in the composition of the tubular fluid at the 
macula densa, resulting from vasopressin's action on water, sodium and urea 
transport in the collecting duct and the resulting recycling of urea in the medulla (see 
review in [9]). Uosm, the most direct reflect of the urine concentrating activity, is rarely 
measured in large cohorts because of technical issues (see below). The present 
study, in a cross-sectional design, describes two practical, easily accessible 
surrogates of Uosm and assesses their validity by comparing the results to the actually 
measured Uosm in large cohorts of the population and in a group of patients with 
CKD. We also checked the value of these surrogates in various sample types (spot 
or 24-h, day and night), and according to gender and to renal function. 
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Our results show that the estimated Uosm, based on sodium, potassium and 
urea concentrations, is an excellent surrogate of the measured Uosm. In most cases, 
eUosm is within ± 5 % of mUosm. This is similarly true in men and women, as well as in 
urine collected during day or night, and in patients with impaired renal function at any 
level of GFR. One may wonder how eUosm and mUosm may be so close when the 
formula used for the calculation of eUosm neglects the minor solutes that should 
however represent more than 5 % of all urinary solutes. This is partly explained by 
the fact that the units are not the same. eUosm is expressed in mosm/L while mUosm is 
in mosm/kg H2O. Because one liter of water with dissolved solutes weights more 
than 1 kg, the osmolality is lower than the osmolarity. The two measures differ only 
modestly for solutions within the biological range. For example, a solution containing 
140 mmol/L NaCl and 500 mmol/L urea has an osmolarity of 780 mosm/L and an 
osmolality of 751 mosm/kg H2O (i.e. 3.7 % lower). This difference partially 
compensates for the missing solutes and thus contributes to the almost equality of 
eUosm and mUosm. Another factor is that electrolytes are assumed to be totally 
dissociated in the eUosm formula. Although the dissociation is high in solutions within 
the physiological range, it is less than 100%, thus also contributing to modestly 
overestimate eUosm. 
 
UCI is a less accurate reflection of mUosm than eUosm because creatinine is 
known to undergo some secretion as well as some reabsorption along the tubule. 
The net result of these opposite effects depends on the rate of urine flow [44]. Our 
study shows that individual values are fairly dispersed and the correlations between 
the two variables are not linear. However, when no other approach is available, UCI 
remains a possible surrogate of urine concentration, provided it is applied to subjects 
with normal renal function. As clearly demonstrated in the present study, UCI 
diverges markedly from mUosm in patients with CKD – limiting its use when renal 
function is impaired and probably also when abnormal handling of creatinine or 
excessive 24-h intake of creatine are suspected.  
 
A few alternative methods for quantifying urine concentration have been used. 
Urine density (UD) (or specific gravity) may be evaluated in 7 colored grades with 
commercially available dipsticks  (Labtix 8SG and Multistix 8SG AMES/Bayer 
Diagnostics) or evaluated by refractometry using a hand-held refractometer (Pen 
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Urine S.G., Atago, Tokyo, Japan) [45]. In the D.E.S.I.R. study (a cohort of the French 
population), UD was measured with dipsticks in fresh spot morning urine samples 
from 1604 subjects, and eUosm was calculated (same formula as here) [8]. Median 
[IQR] eUosm was 664 [272] mosm/L. UD was well correlated with eUosm (r = 0.446, P 
< 0.00001). Another studie showed that UD was well correlated with measured Uosm 
but the wide dispersion made it "impossible to use UD as a dependable clinical 
estimate of Uosm" [46]. Moreover, UD or specific gravity cannot be used if urine 
contains proteins or glucose [47].  
 
 It is important to note that Uosm varies greatly among different subjects, as 
shown in the four populations of the present study and in a few previous reports [31, 
42]. In usual conditions, some subjects produce hypo-osmotic urine while others 
show Uosm  up to 1200 mosm/kg H2O. This wide range of spontaneous Uosm is 
possibly due to large inter-individual variations in the daily solute load [48], in fluid 
intake [42], and in thresholds for vasopressin secretion and/or thirst that are, in part, 
genetically determined [49]. Both vasopressin concentration and urine osmolarity are 
known to differ between sexes. Men have higher vasopressin/copeptin levels [50, 18, 
21] and higher Uosm than women [31]. This difference is mostly due to the fact that 
men excrete a larger osmolar load than women with a higher urine osmolality but an 
approximatively similar 24-h urine volume [31, 51]. Therefore, in studies using these 
variables, data for the two sexes are often presented separately. We verified here the 
validity of the two surrogates in each gender. For both genders, the relation between 
eUosm and mUosm is highly significant and the regression line between these two 
variables is very close to the identity line. The UCI also reflected this gender 
difference but tended to underestimate it slightly, possibly because of the known 
difference in creatinine handling in men and women. 
 
Differences in the usual urine concentration may be associated with the ethnic 
background. A few studies showed that African Americans tend to concentrate urine 
about 20% more than Caucasians and have higher vasopressin levels [52, 30, 53]. 
To our knowledge, very few studies have evaluated other possible differences in 
usual urine concentration related to habitat or ethnic background [54-58]. 
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 The results of the SKIPOGH study illustrate the fact that urine is usually on the 
average more concentrated during the night than during the day by about 50-100 
mosm/kg H2O. Few studies have investigated day and night urine separately [59-61]. 
They showed that the circadian pattern of urine flow rate/urine concentration and/or 
sodium excretion rate may be disturbed in some subjects. An excessive urine 
concentration during daytime, limiting sodium and/or water excretion rate, is 
subsequently compensated at night by the pressure-natriuresis mechanism [62, 59-
61, 63]. Accordingly, measurement of urine osmolality in overnight urine samples 
may not be representative of 24-h urine.  
There are several advantages for using surrogates of urine osmolality. 
Osmometers, based on either freezing point depression or vapor pressure methods, 
are expensive and rarely equipped with automatic sample changers. Each 
measurement lasts a minute or two (due to the time needed to freeze or heat the 
sample, respectively), thus allowing some evaporation if samples are loaded in the 
changer in advance. We tested the automatic changer and observed that mUosm 
values in the same sample increased after 10 loads. In studies involving a large 
number of subjects in which individual measurements are practically impossible, 
values may increase artifactually depending on the timing of the measurements. 
Moreover osmolality measurements cannot be coupled with measurements of 
various solutes performed by automatic analyzers; they thus require separate 
aliquots and time-consuming manipulations. The excellent correlation between eUosm 
and mUosm, over the whole range of mUosm values, even in CKD, validate eUosm as an 
appropriate surrogate of mUosm, especially in large cohorts.  
 
Urine electrolytes are often available in epidemiological studies, but urea, 
needed for the calculation of eUosm, is less frequently measured. When new 
measurements are initiated on previously stored samples in order to evaluate the 
kidney's concentrating activity, authors should consider the respective advantages of 
measuring either osmolality or urea concentration. Urea is much easier, quicker and 
cheaper to measure than osmolality. Moreover, it will also provide data for a 
significant solute in the urinary concentrating process, and allow an indirect 
evaluation of protein intake. 
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 This study has some limitations. It concerns exclusively subjects of European 
descent. Studies in subjects of other ethnic backgrounds are required. The possible 
influence of socio-demographic factors has not been considered. However, we think 
it is reasonable to assume that the highly significant correlations between eUosm and 
mUosm, and the relatively good relationships of UCI with mUosm are not dependent 
upon the population under study and may be extended to all populations, as long as 
the measurements of sodium, potassium, urea and creatinine concentrations are 
performed in appropriately equipped laboratory with rigorous methods.  
 
 In summary, the present study validates, in large cohorts, the use of an 
"estimated osmolarity", based on the measurement of sodium, potassium and urea, 
as an excellent surrogate of the measured urine osmolality. It also shows that the 
"urine concentrating index", based on the ratio of creatinine concentrations in plasma 
and urine, may be used as a relative index of urine concentration only in subjects 
with normal renal function because of the disturbed handling of creatinine in CKD. In 
contrast, eUosm is valid whatever the level of renal function. In future epidemiologic 
studies addressing the influence of vasopressin and urinary concentrating activity, 
the use of the "estimated urine osmolarity" should be recommended when the actual 
urine osmolality cannot be measured.  
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TABLES 
 
 
TABLE 1.  Demographic information about the different cohorts 
 
Means + SEM  or median (interval). 
 
 
 
 
TABLE 2. Osmolality and its surrogates in 147 CKD patients according to the level of 
renal function 
 
 
Means ± SEM.   
CKD stages are shown with the limits of eGFR in ml/min per 1.73 m2. 
Spot mUosm = mUosm of a morning spot urine sample. All other values concern 
24-h urine collection. 
(1) For the ratio of UCI/mUosm. UCI was multiplied by 100 to make the reading 
easier. 
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FIGURE LEGENDS 
 
Figure 1. Comparison of urine osmolality surrogates with measured urine osmolality. 
A. Linear correlation between measured osmolality and estimated osmolarity in 3 
cohorts. CROATIA-Korcula: mUosm =  1.03 eUosm + 3.3 (p<0.001, r = 0.98); GS:SFHS 
Aberdeen: mUosm =  0.99 eUosm – 4.4 (p<0.001, r = 0.98);  GS:SFHS Glasgow:. 
mUosm =  0.96 eUosm + 11 (p<0.001, r = 0.99). The thin vertical lines show mUosm of 
300 and 900 mosm/kg H2O, i.e. approximatively one time and three times the plasma 
osmolality. B. Quadratic correlation between UCI and measured urine osmolality in 3 
cohorts. . CROATIA- Korcula: mUosm = 5.04 UCI – 0.009 UCI
2 + 126 (p<0.001, r = 
0.76);  GS:SFHS Aberdeen: mUosm = 5.52 UCI – 0.009 UCI
2 + 28 (p<0.001, r = 0.90);  
GS:SFHS Glasgow: mUosm = 4.89 UCI – 0.006 UCI
2 + 90 (p<0.001, r = 0.89). Black 
lines represent the best-fit curves. Red thin lines represent the 95% confidence 
intervals. Dotted lines in the top panel represent the medians.  
 
Figure 2. Daytime and night-time urine in the SKIPOGH population (n= 925).  
A. Distribution of mUosm among SKIPOGH subjects. Thin curves represent the 
normal distribution model. B. Linear correlation between measured and estimated 
Uosm in daytime and night-time urine. C. Quadratic correlation between UCI and 
mUosm in daytime versus night-time urine. In B and C, black lines represent the best-
fit curves and red thin lines 95% confidence intervals. Dotted lines in B represent the 
medians.  
 
Figure 3. Bland-Altman plots showing the agreement between estimated and 
measured Uosm in the spot urine samples of GS:SFHS Aberdeen (top), the day urine 
samples of SKIPOGH (middle) and the 24-h urine of the CKD patients. 
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TABLE 1  
 
 
Cohort 
CROATIA-
Korcula 
GS:SFHS 
Aberdeen 
GS:SFHS 
Glasgow 
SKIPOGH 
 Day 
SKIPOGH  
Night 
CKD Necker 
N 463 554 2305 925 idem 146 
Sample type  Spot Spot Spot Day period Night period 24 h 
Age, y 58 (19 – 87)  57 (19 - 88) 53 (18 - 93) 47 (18 - 90) idem 64 (17 - 86) 
Gender : M / W, %  41 / 59 43 / 57 41 / 59 47 / 53 idem 59 / 41 
BMI 27.97 ± 0.21 27.22 ± 0.22 26.97 ± 0.21 25.03 ± 0.15 idem 24.16 ± 0.30 
mUosm, mosm/kg H2O 668 ± 10 524 ± 10 540 ± 5 457 (110 – 1174) 541 (67 – 1304) 396 ± 13 
eUosm, mosm/L 664 ± 9 526 ±11 547 ±5 450 (118 – 1142) 513 (61 – 1223) 381 ± 12 
UCI 165 ± 4 119 ± 3 117 ± 2 114 ± 2 145 ± 3 41.6 ± 3.6 
Uurea, mmol/L 285 ± 5 225 ± 5 250 ± 3 227 ± 4 296 ± 5 177 ± 6 
UNa, mmol/L 113.8 ± 2.2 79.3 ± 2.0 83.9 ± 1.0 94.8 ± 1.6 93.4 ± 1.6 68.7 ± 2.8 
UK, mmol/L 65.9 ± 1.6 63.5 ± 1.5 64.9 ± 0.8 47.4 ± 0.8 32.7 ± 0.6 33.3 ± 1.3 
eGFR . ml/min/1.73 m2 83.4 ± 1.1 92.2 ± 0.7 89.1 ± 0.4 96.3 ± 0.6 — 46.2 ± 2.5 
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TABLE 2 
 
 
CKD Stage N 
Creatinine 
Excretion Spot mUosm mUosm eUosm eUosm / mUosm UCI UCI*100 / mUosm 
   mmol/d 
mosm/kg 
H2O 
mosm/kg 
H2O 
mosm/L  
(Ucreat 
/Pcreat) 
(1) 
         
Stage 1 (>90) 13 13.4 ± 1.0 738 ± 61 650 ± 48 608 ± 43 0.94 ± 0.01 146 ± 17 22.1 ± 1.6 
Stage 2 (60-89) 29 13.2 ± 0.7 517 ± 32 479 ± 34 458 ± 34 0.95 ± 0.01 59 ± 5 12.3 ± 0.4 
Stage 3 (30-59) 54 11.5 ± 0.5 450 ± 14 371 ± 14 358 ± 14 0.97 ± 0.01 34 ± 2 9.2 ± 0.3 
Stage 4 (15-29) 32 9.4 ± 0.5 376 ± 13 321 ± 13 311 ± 12 0.98 ± 0.01 17 ± 1 5.2 ± 0.3 
Stage 5 (<15) 19 8.1 ± 0.5 318 ± 11 296 ± 12 291 ± 12 0.98 ± 0.02 7 ± 1 2.5 ± 0.2 
 
 
 
 
Page 50 of 53American Journal of Nephrology
For Peer Review
Korcula GS:SFHS Aberdeen GS:SFHS Glasgow 
e
U
o
s
m
 (
m
o
s
m
/L
) 
mUosm (mosm/kg H2O) mUosm (mosm/kg H2O) 
e
U
o
s
m
 (
m
o
s
m
/L
) 
U
C
I 
mUosm  (mosm/kg H2O) 
U
C
I 
mUosm  (mosm/kg H2O) 
U
C
I 
 
mUosm  (mosm/kg H2O) 
e
U
o
s
m
 (
m
o
s
m
/L
) 
mUosm (mosm/kg H2O) 
Youhanna et al. Surrogates of urine osmolality.   Figure 1  
A 
B 
Page 51 of 53 American Journal of Nephrology
For Peer Review
F
re
q
u
e
n
c
y
 (
%
) 
 
mUosm (mosm/kg H2O) 
F
re
q
u
e
n
c
y
 (
%
) 
mUosm (mosm/kg H2O) 
mUosm (mosm/kg H2O) 
e
U
o
s
m
 (
m
o
s
m
/L
) 
mUosm (mosm/kg H2O) 
Day  
Night  
mUosm (mosm/kg H2O) 
e
U
o
s
m
 (
m
o
s
m
/L
) 
U
C
I 
 
mUosm (mosm/kg H2O) 
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Supplementary Table 1 . Results of Bland-Altman tests comparing estimated Uosm to measured Uosm. 
in the different populations 
 
 
 
Cohort Mean of differences  (mmol/L) 
95% limit of  
agreement 
GS:SFHS Aberdeen - 6 - 54 to 43 
GS:SFHS Glasgow - 23 - 80 to 34 
CROATIA-Korcula 24 - 44 to 90 
SKIPOGH day  9 - 71 to 89 
SKIPOGH night  24 - 66 to 114 
CKD patients 15 - 37 to 67 
   
 
The mean of differences corresponds to mUosm – eUosm. 
  
Youhanna et al. Surrogates of urine osmolality. February 2017 
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Supplementary Table 2. Osmolality and its surrogates in men and women in three different cohorts 
 
          
 
Cohort N mUosm eUosm UCI eUosm/ mUosm 
UCIx100/ mUosm 
(1) r 
 Men        
 CROATIA-Korcula 187 722 ± 13 697± 13 161 ± 2 0.97 ± 0.004 21.97 ± 0.53 0.98 
 GS:SFHS Aberdeen 240 609 ± 16 615± 16 137 ± 5 1.01 ± 0.003 21.64 ± 0.39 0.99 
 GS:SFHS Glasgow 946 606 ± 8 616 ± 8 130 ± 3 1.01 ± 0.002 20.67 ± 0.21 0.99 
 
 Women        
 CROATIA-Korcula  264 627 ± 13 604 ± 13 168 ± 6  0.97 ± 0.003 26.50 ± 0.67 0.98 
 GS:SFHS Aberdeen 312 450 ± 13 455 ± 13 106 ± 4 1.02 ± 0.003 22.80 ± 0.41 0.99 
 GS:SFHS Glasgow 1359 493  ± 7 499 ± 7 108 ± 2 1.01 ± 0.002 20.76 ± 0.18 0.99 
 
 Ratio Men/Women 
 CROATIA-Korcula 
 1.15 1.15 0.95      
 GS:SFHS Aberdeen 
 1.35 1.35 1.29      
 GS:SFHS Glasgow 
 1.23 1.23 1.20      
 
 mUosm in mosm/kg H2O;  eUosm in mosm/L;   UCI = Ucreatinine/Pcreatinine 
          Means ± SEM.   
        (1) For the ratio of UCI/mUosm. UCI was multiplied by 100 to make the reading easier. 
 
